SCHEMBL7420256

SCHEMBL7420256

Cc1nc(C#Cc2nccs2)cs1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 18/20 0.57
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15870993 0.77 GRM5 (0.68) GRM5
SCHEMBL4154142 0.72 GRM5 (1.00) GRM5CYP1A2CYP2D6
SCHEMBL15049682 0.72 GRM5 (1.00) GRM5CYP1A2CYP2D6
SCHEMBL7426422 0.71 GRM5 (0.56) GRM5CYP1A2CYP2D6
SCHEMBL14006347 0.71
SCHEMBL28749297 0.70
SCHEMBL4151041 0.69 GRM5 (1.00) GRM5CYP1A2CYP2D6
SCHEMBL4144709 0.69 GRM5 (1.00) GRM5CYP1A2CYP2D6
SCHEMBL5805253 0.69
SCHEMBL1243386 0.68 GRM5 (0.56) GRM5CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed